NASDAQ:UPI (UPI) (UPI) Stock Price, News & Analysis → The Presidential candidate you should REALLY be worried about (From Stansberry Research) (Ad) Free UPI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume124,964 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (UPI) alerts: Email Address Ad Stansberry ResearchThe Presidential candidate you should REALLY be worried aboutThe Presidential candidate you should REALLY be worried about Most Americans are overlooking the seemingly impossible candidate that should worry you. It's not Biden… Trump… Newsom… or even Michelle. It's someone even worse. New evidence of a secret plan indicates he could soon return, and finish what he started.Get the full story right here. About (UPI) Stock (NASDAQ:UPI)Cogentix Medical, Inc. (Cogentix Medical) is a medical device company. The Company is engaged in the design, development, manufacturing and marketing of products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, known as EndoSheath technology, providing users with endoscope turnover. The Company's products include Urgent PC Neuromodulation System, Macroplastique Bulking Agent, Endoscopy Systems and EndoSheath Technology. The Company is also engaged in the commercialization of the Urgent PC Neuromodulation System, a device which delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). Its Macroplastique is an injectable soft-tissue bulking agent used to treat stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD). The Company offers 5000 and 7000 series of endoscopes, which are video endoscopy systems.Read More Ad Stansberry ResearchThe Presidential candidate you should REALLY be worried aboutThe Presidential candidate you should REALLY be worried about Most Americans are overlooking the seemingly impossible candidate that should worry you. It's not Biden… Trump… Newsom… or even Michelle. It's someone even worse. New evidence of a secret plan indicates he could soon return, and finish what he started.Get the full story right here. UPI Stock News HeadlinesMay 15 at 11:21 AM | msn.comFintech Unicorn Zeta Rolls Out UPI-Integrated CreditMay 15 at 11:21 AM | msn.comPhonePe Partners With LankaPay To Introduce UPI Payments In Sri LankaMay 10, 2024 | msn.comFintech firm Zeta launches UPI-linked digital credit service for banks | Here’s how this will workMay 10, 2024 | reuters.comIndian cenbank meets stakeholders to widen scope, reach of UPIMay 10, 2024 | msn.comZeta eyes 50% of the $1trn Credit Line on UPI banking tech opportunity by 2030May 10, 2024 | techcrunch.comIndia likely to delay UPI market caps in win for PhonePe-Google Pay duopolyMay 10, 2024 | reuters.comExclusive: India to again delay caps on UPI payments market shareMay 8, 2024 | msn.comKolkata Metro Rail addresses cash change issue, introduces UPI-based ticketing system – Here’s how it’s going to workMay 5, 2024 | msn.comPaytm to offer ₹100 cashback to UPI users post NPCI approval for migration to PSP banksMay 5, 2024 | msn.com‘Always check bank acc’: Bengaluru woman warns of UPI SMS scam, Netizens react, ‘Jamtara in real life’May 5, 2024 | msn.comPaytm Now Provides Various UPI IDs For Users: Here's How To Change Yours QuicklyMay 5, 2024 | msn.comBEWARE Of UPI SMS Scam! Bengaluru Woman’s Personal Experience Will Rattle YouMay 5, 2024 | msn.comIs UPI making you overspend or helping you save money?April 28, 2024 | msn.comWhat is the PPI Charge on UPI Payments? Who Does it Affect and What You Need to Know?April 27, 2024 | msn.comTouched 5 Million UPI Transactions Monthly After Paytm Partnership: Yes Bank CEOApril 27, 2024 | msn.comBreak the duopoly in the UPI payments ecosystemApril 27, 2024 | msn.comYes Bank recorded 5 mn UPI transactions per month after Paytm tie-up: CEO Prashant KumarApril 25, 2024 | msn.comCaleb Williams' message for Bears fans before NFL draft: 'I'm ready to go'April 16, 2024 | msn.comAmazon Pay to tie up with NPCI for credit services on UPI platform: ReportApril 15, 2024 | msn.com'BHIM UPI which you use for digital payments, we've named it after Babasaheb Ambedkar...': PM ModiApril 14, 2024 | msn.comUPI drill for seniors, Ayushman Bharat to cover all above 70 yearsApril 14, 2024 | msn.comMobiKwik's Pocket UPI: Here's how you can use it to make payments without linking bank accountsApril 14, 2024 | msn.comRBI's new UPI rule change for PPIs: Soon, you can use money in PhonePe, Amazon Pay wallets to pay via any UPI appApril 12, 2024 | msn.comSachin Bansal's Navi starts offering cashbacks for UPI payments as it looks to expand financial servicesApril 11, 2024 | msn.comIndia's UPI transactions outpace US digital payments, says S JaishankarSee More Headlines Receive UPI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (UPI) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:UPI Previous SymbolNYSE:UPI CUSIPN/A CIK890846 Webwww.uroplasty.com Phone+1-952-4266140FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report UPI Stock Analysis - Frequently Asked Questions What other stocks do shareholders of (UPI) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (UPI) investors own include Acer Therapeutics (ACER), Aralez Pharmaceuticals (ARLZ), Bioanalytical Systems (BASI), (CASC) (CASC), CASI Pharmaceuticals (CASI), Catalyst Biosciences (CBIO), Cleveland BioLabs (CBLI), Avid Bioservices (CDMO), Cerus (CERS) and Cognyte Software (CGNT). This page (NASDAQ:UPI) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceDems have chosen Biden replacement?Paradigm PressThe Next Industry Being Reshaped By AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchShocking $16T Elon Musk Crypto LeakCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlace[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (UPI) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.